🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
276

Quick answer

Takeda has 276 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. TAK-981

    Takeda

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  3. TAK-988

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  4. TAK-994

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    2 trials

  5. TAK-994

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. TAK-994 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. TAKC-02

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  8. TBio-6517

    Takeda

    Solid Tumor

    phase 1 mab terminated

    1 trial

  9. TDV - Low Dose

    Takeda

    Dengue Fever

    phase 1 mab completed

    1 trial

  10. Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

    Takeda

    Healthy

    phase 1 mab completed

    1 trial

  11. Teduglutide

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  12. Teduglutide

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  13. Trebananib 3 mg/kg

    Takeda

    Neoplasms, Advanced Solid

    phase 1 small molecule completed

    1 trial

  14. VP 20629

    Takeda

    Friedreich's Ataxia

    phase 1 small molecule completed

    1 trial

  15. Vedolizumab SC

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    4 trials

  16. Vedolizumab SC

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  17. Vortioxetine

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  18. Vortioxetine

    Takeda

    Severe Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  19. Vortioxetine

    Takeda

    Healthy Adult Participants

    phase 1 small molecule completed

    1 trial

  20. Zasocitinib

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. [14C] Subasumstat

    Takeda

    Solid Tumors

    phase 1 small molecule terminated

    1 trial

  22. [14C]-TAK-385 Oral Solution

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  23. [14C]-TAK-954

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  24. [68Ga]MLN6907

    Takeda

    Imaging of Solid Gastrointestinal Tumors

    phase 1 small molecule completed

    1 trial

  25. [^14C]-alisertib

    Takeda

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  26. alisertib

    Takeda

    Advanced Malignancies

    phase 1 small molecule completed

    2 trials

  27. alisertib

    Takeda

    Acinar Cell Adenocarcinoma of the Pancreas

    phase 1 small molecule completed

    1 trial

  28. eASC

    Takeda

    Localized Adverse Reaction to Administration of Drug

    phase 1 gene therapy completed

    1 trial

  29. immediate release guanfacine hydrochloride

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. lumbar puncture

    Takeda

    Crohn's Disease

    phase 1 small molecule completed

    1 trial

  31. namilumab (MT203)

    Takeda

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial

  32. placebo control

    Takeda

    Hemophilia

    phase 1 small molecule terminated

    1 trial

  33. rhASA - Dose Level 1

    Takeda

    Metachromatic Leukodystrophy (MLD)

    phase 1 mab completed

    1 trial

  34. rhPTH(1-84)

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  35. sulfamethoxazole + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  36. teduglutide

    Takeda

    Pharmacokinetics and Safety of Elevated Doses

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

276 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.